- Home
- DWTX vs FBGL Comparison
DWTX vs FBGL Comparison
Compare DWTX & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DWTX
- FBGL
- Stock Information
- Founded
- DWTX 2012
- FBGL 1996
- Country
- DWTX United States
- FBGL Singapore
- Employees
- DWTX N/A
- FBGL N/A
- Industry
- DWTX
- FBGL Miscellaneous manufacturing industries
- Sector
- DWTX
- FBGL Consumer Discretionary
- Exchange
- DWTX NYSE
- FBGL Nasdaq
- Market Cap
- DWTX 9.2M
- FBGL 8.4M
- IPO Year
- DWTX N/A
- FBGL 2025
- Fundamental
- Price
- DWTX $4.79
- FBGL $0.62
- Analyst Decision
- DWTX Strong Buy
- FBGL
- Analyst Count
- DWTX 1
- FBGL 0
- Target Price
- DWTX $10.00
- FBGL N/A
- AVG Volume (30 Days)
- DWTX 27.2K
- FBGL 55.9K
- Earning Date
- DWTX 08-14-2025
- FBGL 01-01-0001
- Dividend Yield
- DWTX N/A
- FBGL N/A
- EPS Growth
- DWTX N/A
- FBGL N/A
- EPS
- DWTX N/A
- FBGL N/A
- Revenue
- DWTX N/A
- FBGL $10,146,582.00
- Revenue This Year
- DWTX N/A
- FBGL N/A
- Revenue Next Year
- DWTX N/A
- FBGL N/A
- P/E Ratio
- DWTX N/A
- FBGL N/A
- Revenue Growth
- DWTX N/A
- FBGL N/A
- 52 Week Low
- DWTX $1.62
- FBGL $0.44
- 52 Week High
- DWTX $29.28
- FBGL $5.45
- Technical
- Relative Strength Index (RSI)
- DWTX N/A
- FBGL N/A
- Support Level
- DWTX N/A
- FBGL N/A
- Resistance Level
- DWTX N/A
- FBGL N/A
- Average True Range (ATR)
- DWTX 0.00
- FBGL 0.00
- MACD
- DWTX 0.00
- FBGL 0.00
- Stochastic Oscillator
- DWTX 0.00
- FBGL 0.00
About DWTX DOGWOOD THERAPEUTICS INC
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.